USPTO serial 99579692
ASCEPLUS
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- WOLFSEN, CHRISTIANNE LISBETH
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with ASCEPLUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chungcheongbuk-do, KR
Chungcheongbuk-do, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
LEIGH ANN LINDQUIST
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000WASHINGTON, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents affecting peripheral nervous system; veterinary substances, namely, veterinary substances used for wound healing, skin disorder treatment and inflammatory disease treatment; veterinary preparations for the treatment of wounds, skin disorders and inflammatory diseases; stem cells for veterinary purposes; ophthalmic preparations; cells for medical purposes; reagents for medical use; drugs for medical purposes for the treatment of wounds, skin disorders and inflammatory diseases; stem cells for medical purposes; skin anti-aging preparations for medical use; medicinal preparations for stimulating hair growth; pharmaceutical skin lotions; pharmaceutical compositions for the treatment of wounds, skin disorders and inflammatory diseases; pharmaceuticals for the treatment of wounds, skin disorders and inflammatory diseases; transplants, namely, implants comprising living tissue; human allograft tissue; biological biomaterials for tissue restoration, namely, biological cell extracts for medical purposes, biological cell culture extracts for medical purposes; injectable dermal fillers; implantable medicines, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treating wounds, skin disorders and inflammatory diseases; surgical implants comprising living tissue grown from stem cells; pharmaceutical preparations acting on the central nervous system; dermatological pharmaceutical products; pharmaceutical preparations for skin whitening; pharmaceutical preparations for skin moisturizing; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for skin regeneration | ACTIVE | — |
| 010 | Medical apparatus for injecting fillers, namely, injection needles, injection syringes, jet injectors for medical use; artificial skin for surgical purposes; artificial implants for skin regeneration | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 9, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 3, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 14, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 4, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 24, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 6, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 6, 2026 | NWAP | NEW APPLICATION ENTERED | — |